Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

CompletedOBSERVATIONAL

Enrollment

19,522

Participants

Timeline

Start Date

January 14, 2004

Primary Completion Date

November 29, 2024

Study Completion Date

November 29, 2024

Conditions

Breast CancerProstate CancerLung CancerSarcomaMelanoma

Trial Locations (1)

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00026754 - Eligibility Screening for the NIH Intramural Research Program Clinical Protocols | Biotech Hunter | Biotech Hunter